0001209191-17-065659.txt : 20171214 0001209191-17-065659.hdr.sgml : 20171214 20171214160728 ACCESSION NUMBER: 0001209191-17-065659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171212 FILED AS OF DATE: 20171214 DATE AS OF CHANGE: 20171214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bermingham Nessan CENTRAL INDEX KEY: 0001377759 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 171256245 MAIL ADDRESS: STREET 1: 890 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-12 0 0001652130 Intellia Therapeutics, Inc. NTLA 0001377759 Bermingham Nessan C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130 CAMBRIDGE MA 02139 1 1 0 0 President & CEO Stock Option (right to buy) 18.295 2017-12-12 4 A 0 292500 0.00 A 2027-12-11 Common Stock 292500 292500 D This option was granted on December 12, 2017 with respect to 292,500 shares of Common Stock, with 25% vesting on December 12, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter. /s/ Jose Rivera, Attorney-In-Fact 2017-12-14